Medically reviewed by Brian Bezack, DO Key Takeaways Primatene Mist is the only OTC inhaler approved by the FDA for mild asthma in people 12 and older.Primatene Mist uses epinephrine, while albuterol ...
Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...
As-needed albuterol-budesonide (Airsupra) more effectively improved lung function in moderate-to-severe asthma than as-needed albuterol only, according to research presented at the CHEST annual ...
Please provide your email address to receive an email when new articles are posted on . Patients with mild asthma are still at risk for severe exacerbations, which can impact their quality of life.